The Green Rush 
Bob Dagher, Chief Medical Officer at Enveric Biosciences
by Nick Opich on March 31, 2022 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
This week on The Green Rush, Anne and Nick are back with a new episode with guest Bob Dagher, Chief Medical Officer at Enveric Biosciences (NASDAQ: ENVB), a cutting-edge neuroscience company developing next-generation, psychedelic-inspired mental health medicines.
Leading the company’s drug development and commercialization efforts, Bob has a long history helping life sciences companies to create innovative solutions that meet the needs of millions of patients around the world. At Enveric, he is currently focused on conditions that include cancer-related distress, PTSD and more.
In this episode our hosts explore with Bob how Enveric is working to alleviate the suffering of patients with cancer-related distress, the Company’s recently announced collaboration with the University of Calgary’s Hotchkiss Brain Institute, Enveric’s patent portfolio and the themes and developments within the psychedelic industry that Bob is looking out for through the rest of 2022.
So sit back and enjoy our conversation with Bob Dagher of Enveric Biosciences.
Links and mentions in the show
Links to the guest’s company and social media accounts
- Enveric’s Twitter: https://twitter.com/Enveric_bio
- Enveric’s LinkedIn: https://www.linkedin.com/company/EnvericBio/
- Bob’s LinkedIn: https://www.linkedin.com/in/bobdaghermd/
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
More Episodes
Ken Jordan, CEO, Co-Founder & Editorial Director of Lucid News
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Ken Jordan, CEO, Co-Founder and Editorial Director of Lucid News. Ken joins us this week […]
Dennis McKenna, Ethnopharmacologist, Director & President of the McKenna Academy of Natural Philosophy
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Emmaline Lewis are back for a new episode with special guest Dr. Dennis McKenna, Ethnopharmacologist and the Director and President of the McKenna Academy of Natural […]
Jess Tyler, Chief Revenue & Experience Officer at MJBiz
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Jess Tyler, Chief Revenue and Experience Officer at MJBiz and MJBizCon. Jess joins us this […]
Stephen N. Xenakis, MD (BG, USA Ret), Executive Director of the American Psychedelic Practitioners Association
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Lewis Goldberg are back for a new episode with special guest Brigadier General (Ret.) Stephen N. Xenakis, MD, Executive Director of the American Psychedelic Practitioners Association […]
